At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Low Dose Ketamine for Blunt Thoracic Trauma: A Prospective Randomized Trial
In Brief
A Phase 4 clinical trial evaluating Ketamine 1 Mg/mL-NaCl 0.9% Intravenous Solution for Blunt Injury of Thorax and Multiple Rib Fractures, Involving Three Ribs. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The goal of this Randomized controlled double-blinded trial is to compare the addition of a ketamine infusion to placebo, when added to standard care in adult blunt trauma patients with multiple rib fractures. The main question it aims to answer are: • addition of low dose ketamine infusion (LDKI) decreases narcotic use • does LDKI impact pulmonary complications, readmission, or hospital length of stay Participants will receive usual standard of care with up to 48 hours of LDKI or placebo. If there is a comparison group: Researchers will compare infusion of a saline infusion to LDKI to see if LDKI decreases need for narcotic analgesics use.
Study Details
Timeline
Interventions
administered at rate of 0.1 mg/kg/hr